NASLA LOYA: Open Payments
NPI 1467875013 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,312 in 99 payments from 19 companies in 2025. Trend: 2023 $687 · 2024 $3,786 · 2025 $4,312
Food & beverage: $2,883Speaker / faculty: $1,339Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $2,130 |
| Janssen Biotech, Inc. | 23 | $709 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $303 |
| Phathom Pharmaceuticals, Inc. | 6 | $264 |
| Janssen Scientific Affairs, LLC | 5 | $142 |
| Aimmune Therapeutics, Inc. | 4 | $140 |
| QOL Medical, LLC | 4 | $125 |
| CONMED Corporation | 1 | $108 |
| Lilly USA, LLC | 3 | $64 |
| Ardelyx, Inc. | 2 | $53 |
Products named: TREMFYA, SKYRIZI, VOQUEZNA, ENTYVIO, LINZESS, Sucraid, ZENPEP, AIRSEAL.
Industry payments across WA — which companies pay providers there.
